Patrick Leroy

Target (United States)

Papers

1

Total Citations

11

H-Index

1

About

Patrick Leroy is a leading figure in the development of high-throughput biophysical screening technologies, with a primary focus on advancing antibody discovery and therapeutic development. His most cited work, "Automated High-Throughput Flow Cytometry for High-Content Screening in Antibody Development" (2018, 11 citations), addresses a critical bottleneck in drug discovery: the labor-intensive nature of traditional flow cytometry. By pioneering an automated, high-content screening platform, Leroy has enabled researchers to leverage the sensitivity and accuracy of flow cytometry as a primary screening method, dramatically accelerating the identification of promising antibody candidates. This contribution is pivotal in an era where antibodies are a dominant therapeutic modality. Leroy’s work bridges the gap between high-information-content assays and the throughput demands of modern drug discovery, making him a key innovator in the field. His research continues to shape how scientists approach large-scale functional screening, offering practical solutions that enhance both efficiency and data quality in preclinical development.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Automated High-Throughput Flow Cytometry for High-Content Screening in Antibody Development
11 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Target (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago